Loongson Technology Corporation (688047.SH) has had its application for issuing A-shares to specific individuals accepted by the Shanghai Stock Exchange.

16:45 16/08/2026

Longxin Zhongke (688047.SH) announced that on August 14, 2026, it received a notification from the Shanghai Stock Exchange (referred to as "SSE") regarding the acceptance of the application for issuing securities by Longxin Zhongke Technology Co., Ltd. for its listing on the Sci-Tech Innovation Board. The SSE verified the prospectus and relevant application documents submitted by the company in accordance with relevant regulations and determined that the application documents were complete and met the legal requirements, deciding to accept the application and conduct the review in accordance with the law.

Loongson Technology Corporation (688047.SH) announced that it received a notice from the Shanghai Stock Exchange (referred to as "SSE") on August 14, 2026, regarding the acceptance of Loongson Technology Corporation's application for the issuance of securities for the Sci-Tech Innovation Board. The SSE verified the offering memorandum and related application documents submitted by the company in accordance with relevant regulations, deemed the application documents complete and in legal form, and decided to accept the application for review in accordance with the law.

Bank of America: Nvidia and Broadcom have the widest holdings, while Micron and AMD have seen significant increases in positions from actively managed funds.

HK Stock Market Move | ASCLETIS-B (01672) rose nearly 5% in early trading as the company launched a Phase I obesity study in the U.S. for ASC36 oral tablets.

HK Stock Market Move | JNBY (03306) opened over 7% higher, with a year-on-year increase in net profit of 11.7%. A total of HKD 1.81 will be distributed as a final dividend, including a special dividend.

Bank of America: Nvidia and Broadcom have the widest holdings, while Micron and AMD have seen significant increases in positions from actively managed funds.

HK Stock Market Move | ASCLETIS-B (01672) rose nearly 5% in early trading as the company launched a Phase I obesity study in the U.S. for ASC36 oral tablets.